Alkem to acquire a 55% stake in Occlutech for €99m.

Alkem, an Indian multinational pharmaceutical company, agreed to acquire a 55% stake in Occlutech, a global medical devices company, for €99m. Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure. Occlutech is the second-largest company in Europe in the minimally invasive cardiac implants segment and the third-largest globally. It operates manufacturing and R&D facilities in Germany and Turkey, a global distribution hub in Sweden, and clinical operations in the US.